Incarcerated intravenous heroin users: Predictors of post-release utilization of methadone maintenance treatment

References

• Taiwan Food and Drug Administration, Ministry of Health and Welfare. The 2012 annual statistic data of substance abuse, 2013; http://www.fda.gov.tw/upload/133/2013071815122080849.pdf (accessed November 8, 2013).
   Google Scholar
• Taiwan National Police Agency, Ministry of the Interior. The 2012 annual report of action against illicit drugs, 2013; http://www.npa.gov.tw/NPAGip/wSite/ct?xItem=63966&ctNode=12594&mp=1 (accessed November 8, 2013).
   Google Scholar
• Zhu WX, Dong JQ, Hesketh T. Preventing relapse in incarcerated drug users in Yunnan Province, China. Drug Alcohol Rev 2009; 28:641–7.
   PubMed Web of Science ®Google Scholar
• van Haastrecht HJ, Bax JS, van den Hoek AA. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction 1998; 93:1417–25.
   PubMed Web of Science ®Google Scholar
• Estebanez P, Zunzunegui MV, Aguilar MD, Russell N, Cifuentes I, Hankins C. The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care 2002; 14:95–104.
   PubMed Web of Science ®Google Scholar
• Yang CH, Yang SY, Shen MH, Kuo HS. The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984–2005. Int J Drug Policy 2008; 19:317–23.
   PubMed Web of Science ®Google Scholar
• Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov 2002; 1:710–26.
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav 2002; 27:155–66.
   PubMed Web of Science ®Google Scholar
• King VL, Stoller KB, Hayes M, et al. A multicenter randomized evaluation of methadone medical maintenance. Drug Alcohol Depend 2002; 65:137–48.
   PubMed Web of Science ®Google Scholar
• Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000; 59:17–31.
   PubMed Web of Science ®Google Scholar
• Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration, and hepatitis C infection. Addiction 2005; 100:820–8.
   PubMed Web of Science ®Google Scholar
• Peters AD, Reid MM. Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian. Drug Alcohol Depend 1998; 50:47–55.
   PubMed Web of Science ®Google Scholar
• O'Connor PG. Methods of detoxification and their role in treating patients with opioid dependence. JAMA 2005; 294:961–3.
   PubMed Web of Science ®Google Scholar
• Ward J, Mattick RP, Hall W. The effectiveness of methadone maintenance treatment: an overview. Drug Alcohol Rev 1994; 13:327–35.
   PubMedGoogle Scholar
• Deck D, Carlson MJ. Access to publicly funded methadone maintenance treatment in two western states. J Behav Health Serv Res 2004; 31:164–77.
   PubMed Web of Science ®Google Scholar
• Shah NG, Celentano DD, Vlahov D, et al. Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 2000; 14:2035–43.
   PubMed Web of Science ®Google Scholar
• Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver. Drug Alcohol Depend 2005; 80:329–35.
   PubMed Web of Science ®Google Scholar
• Booth RE, Corsi KF, Mikulich SK. Improving entry to methadone maintenance among out-of-treatment injection drug users. J Subst Abuse Treat 2003; 24:305–11.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski CF, Booth RE, Lloyd LV. The effects of offering free treatment to street-recruited opioid injectors. Addiction 2000; 95:697–704.
   PubMed Web of Science ®Google Scholar
• Appel PW, Ellison AA, Jansky HK, Oldak R. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders. Am J Drug Alcohol Abuse 2004; 30:129–53.
   PubMed Web of Science ®Google Scholar
• Noroozi M, Nedjat S, Golestan B, Majdzadeh R. What are differences between non-injecting and injecting drug addicts? Int J Prev Med 2012; 3:414–9.
   PubMedGoogle Scholar
• Bukten A, Skurtveit S, Stangeland P, et al. Criminal convictions among dependent heroin users during a 3-year period prior to opioid maintenance treatment: a longitudinal national cohort study. J Subst Abuse Treat 2011; 41:407–14.
   PubMed Web of Science ®Google Scholar
• Gossop M, Marsden J, Stewart D, Rolfe A. Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug Alcohol Depend 2000; 58:165–72.
   PubMed Web of Science ®Google Scholar
• Hakansson A, Berglund M. Risk factors for criminal recidivism—a prospective follow-up study in prisoners with substance abuse. BMC Psychiatry 2012; 12:111.
   PubMed Web of Science ®Google Scholar
• Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. J Opioid Manag 2006; 2:35–41.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association, 2000;
   Google Scholar
• Magura S, Goldsmith DS, Casriel C, et al. Patient-staff governance in methadone maintenance treatment: a study in participative decision making. Int J Addict 1988; 23:253–78.
   PubMed Web of Science ®Google Scholar
• Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine, and amphetamine users. Addiction 1995; 90:607–14.
   PubMed Web of Science ®Google Scholar
• Chen VC, Chen H, Lin TY, et al. Severity of heroin dependence in Taiwan: reliability and validity of the Chinese version of the Severity of Dependence Scale (SDS[Ch]). Addict Behav 2008; 33:1590–3.
   PubMed Web of Science ®Google Scholar
• Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol 1994; 13:39–46.
   PubMed Web of Science ®Google Scholar
• Smilkstein G. The family APGAR: a proposal for a family function test and its use by physicians. J Fam Pract 1978; 6:1231–9.
   PubMed Web of Science ®Google Scholar
• Chen YC, Hsu CC, Hsu SH, Lin CC. A preliminary study of Family Apgar Index. Acta Paediatrica Sinica 1980; 21:210–217.
   Google Scholar
• Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1:385–401.
   Web of Science ®Google Scholar
• Chien CP, Cheng TA. Depression in Taiwan: epidemiological survey utilizing CES-D. Seishin Shinkeigaku Zasshi 1985; 87:335–8.
   PubMedGoogle Scholar
• MacArthur GJ, Minozzi S, Martin N, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012; 345:e5945.
   PubMed Web of Science ®Google Scholar
• Uhlmann S, Milloy MJ, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction 2010; 105:907–13.
   PubMed Web of Science ®Google Scholar
• Reddon H, Milloy MJ, Simo A, Montaner J, Wood E, Kerr T. Methadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users. AIDS Behav 2014; 18:740–6.
   PubMed Web of Science ®Google Scholar
• Mesquita F, Jacka D, Ricard D, et al. Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO). Harm Reduct J 2008; 5:26.
   PubMed Web of Science ®Google Scholar
• Bell J, Burrell T, Indig D, Gilmour S. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990–2002. Drug Alcohol Depend 2006; 81:55–61.
   PubMed Web of Science ®Google Scholar
• Reimer J, Verthein U, Karow A, Schafer I, Naber D, Haasen C. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction 2011; 106:1647–55.
   PubMed Web of Science ®Google Scholar
• Wang PW, Wu HC, Yen CN, et al. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study. Am J Drug Alcohol Abuse 2012; 38:213–9.
   PubMed Web of Science ®Google Scholar
• De Maeyer J, Vanderplasschen W, Camfield L, Vanheule S, Sabbe B, Broekaert E. A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals. Int J Nurs Stud 2011; 48:1244–57.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li L, Zhang Y, et al. Assessment of attitudes towards methadone maintenance treatment between heroin users at a compulsory detoxification centre and methadone maintenance clinic in Ningbo, China. Subst Abuse Treat Prev Policy 2013; 8:29.
   PubMed Web of Science ®Google Scholar
• Rieckmann T, Daley M, Fuller BE, Thomas CP, McCarty D. Client and counselor attitudes toward the use of medications for treatment of opioid dependence. J Subst Abuse Treat 2007; 32:207–15.
   PubMed Web of Science ®Google Scholar
• Hedrich D, Alves P, Farrell M, Stover H, Moller L, Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 2012; 107:501–17.
   PubMed Web of Science ®Google Scholar
• Lin HC, Chen KY, Wang PW, et al. Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan. Subst Use Misuse 2013; 48:181–91.
   PubMed Web of Science ®Google Scholar
• Bargagli AM, Schifano P, Davoli M, Faggiano F, Perucci CA. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy. Drug Alcohol Depend 2005; 79:191–9.
   PubMed Web of Science ®Google Scholar
• Schutz CG, Rapiti E, Vlahov D, Anthony JC. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend 1994; 36:129–38.
   PubMed Web of Science ®Google Scholar
• Wickersham JA, Marcus R, Kamarulzaman A, Zahari MM, Altice FL. Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ 2013; 91:124–9.
   PubMed Web of Science ®Google Scholar
• Grella CE, Joshi V. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study. Am J Drug Alcohol Abuse 1999; 25:385–406.
   PubMed Web of Science ®Google Scholar
• Knight DK, Simpson DD. Influences of family and friends on client progress during drug abuse treatment. J Subst Abuse 1996; 8:417–29.
   PubMedGoogle Scholar
• Fischer B, Cruz MF, Patra J, Rehm J. Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN). J Subst Abuse Treat 2008; 34:340–6.
   PubMed Web of Science ®Google Scholar
• Back SE, Payne RL, Wahlquist AH, et al. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse 2011; 37:313–23.
   PubMed Web of Science ®Google Scholar
• Chiang SC, Chan HY, Chang YY, Sun HJ, Chen WJ, Chen CK. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry Clin Neurosci 2007; 61:105–11.
   PubMed Web of Science ®Google Scholar
• Harris KM, Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv 2005; 56:954–9.
   PubMed Web of Science ®Google Scholar
• Wu LT, Kouzis AC, Leaf PJ. Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am J Psychiatry 1999; 156:1230–6.
   PubMed Web of Science ®Google Scholar
• Cohn AM, Epstein EE, McCrady BS, et al. Pretreatment clinical and risk correlates of substance use disorder patients with primary depression. J Stud Alcohol Drugs 2011; 72:151–7.
   PubMed Web of Science ®Google Scholar
• Chen LY, Strain EC, Crum RM, Mojtabai R. Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression. J Addict Med 2013; 7:325–34.
   PubMed Web of Science ®Google Scholar